A pancreas transplant is an organ transplant that involves implanting a healthy pancreas (one that can produce insulin) into a person who usually has diabetes. Because the pancreas is a vital organ, performing functions necessary in the digestion process, the recipient’s native pancreas is left in place, and the donated pancreas is attached in a different location. In the event of rejection of the new pancreas, which would quickly cause life-threatening diabetes, there would be a significant chance the recipient would not survive very well for long without the native pancreas, however dysfunctional, still in place. The healthy pancreas comes from a donor who has just died or it may be a partial pancreas from a living donor. At present, pancreas transplants are usually performed in persons with insulin-dependent diabetes, who can develop severe complications. Patients with the most common, and deadliest, form of pancreatic cancer(pancreatic adenomas, which are usually malignant, with a poor prognosis and high risk for metastasis, as opposed to more treatable pancreatic neuroendocrine tumors or pancreatic insulinomas) are usually not eligible for valuable pancreatic transplantations, since the condition usually has a very high mortality rate and the disease, which is usually highly malignant and detected too late to treat, could and probably would soon return. Better surgical method can be chosen to minimize the surgical complications with enteric or bladder drainage. Advancement in immunosuppression has improved quality of life after transplantation.
Read more about : What size of ovarian cyst is dangerous?
Read more about : Virgin tightening surgery before and after photo
Read more about : Sign of Anal cancer
In most cases, pancreas transplantation is performed on individuals with type 1 diabetes with end-stage renal disease, brittle diabetes and hypoglycaemic unawareness. However, selected type 2 diabetics can also benefit from a pancreas transplant. The indications for a type 2 diabetic are a BMI<30 kg/m2 and low overall insulin requirement (< 1 U/kg/day). The majority of pancreas transplantation (>90%) are simultaneous pancreas-kidney transplantation.
As of currently, pancreas transplantation remains as the most effective treatments for diabetes. As such, it has improved the quality of life in uremic diabetic patients.
Complications immediately after surgery include thrombosis, pancreatitis, infection, bleeding and rejection. Rejection may occur immediately or at any time during the patient’s life. This is because the transplanted pancreas comes from another organism, thus the recipient’s immune system will consider it as an aggression and try to combat it. Organ rejection is a serious condition and ought to be treated immediately. In order to prevent it, patients must take a regimen of immunosuppressive drugs. Drugs are taken in combination consisting normally of ciclosporin, azathioprine and corticosteroids. But as episodes of rejection may reoccur throughout a patient’s life, the exact choices and dosages of immunosuppressants may have to be modified over time. Sometimes tacrolimus is given instead of ciclosporin and mycophenolate mofetil instead of azathioprine.
Technical failure is a primary complication for a graft failure within the first three months after transplantation. Vascular thrombosis accounts for 50% of these graft failures. Pancreatitis accounts for 20%, infection for 18%, fistulas for approximately 6.5%, and bleeding accounts for about 2.4% of all pancreatic graft failure.
There are four main types of pancreas transplantation:
Standard practice is to replace the donor’s blood in the pancreatic tissue with an ice-cold organ storage in the solution, such as UW (Viaspan) or HTK until the allograft pancreatic tissue is implanted.
The prognosis after pancreas transplantation is very good. Over the recent years, long-term success has improved and risks have decreased. One year after transplantation more than 95% of all patients are still alive and 80–85% of all pancreases are still functional. After transplantation patients need lifelong immunosuppression. Immunosuppression increases the risk for a number of different kinds of infection and cancer.
It is unclear if steroids, which are often used as immunosuppressant, can be replaced with something else.
Read more about: Stages of fissure healing
Read more about: Cancer treatment in Iran
The overall one-year patient survival rate was 91 percent, and the one-year insulin-independent rate (graft functional survival) was 70 percent in the U.S. (n=2573). Five years after surgery, patient survival is 78 percent and pancreas survival (insulin independence) is 60 percent.
More than 95% of people survive the first year after a pancreas transplant. Organ rejection occurs in about 1% of people each year. You must take medicines that prevent rejection of the transplanted pancreas and kidney for the rest of your life.
A pancreas transplant is an operation to treat insulin-dependent diabetes. It gives someone with diabetes a healthy insulin-producing pancreas from a donor who’s recently died. This means they can produce their own insulin and do not need to inject it.
Pancreas transplant surgery carries a risk of significant complications, including: Blood clots. Bleeding. Infection. Most people live for many years, or even decades, after a pancreas transplant. Virtually everyone will live at least a year afterwards, and almost 9 in 10 will live at least 5 years.
Read more about: Intestine transplantation
Read more about: Diabetes Treatment in Iran
Candidates for pancreas transplantation generally have type 1 diabetes, usually along with kidney damage, nerve damage, eye problems, or another complication of the disease. Usually, healthcare providers consider a transplant for someone whose diabetes is out of control even with medical treatment. Patients ages 18 to 55 with a body mass index less than 32 must meet the following criteria to be considered for pancreas transplantation. A complete medical/surgical, cardiac, vascular and psychosocial evaluation will be performed to determine candidacy.
Read more about: pancreas cancer treatment in iran